DFNSVSGTBP• 3 Months (Normalized)
DFNS vs GTBP (T3 Defense Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Jul 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DFNS Performance $6.7
-63.54%
T3 Defense Inc.
Normalized Baseline0.00%
GTBP Performance $6.37
+1325.06%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1388.6 pts
GTBP outperforming by 1388.60 percentage points
DFNSGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DFNS GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | DFNS Price | DFNS Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $6.70 | -63.54% | $6.37 | +1325.06% | -1388.60% |
| Oct 05, 2026 | $6.78 | -63.10% | $6.16 | +1278.08% | -1341.18% |
| Oct 02, 2026 | $7.34 | -60.05% | $6.10 | +1264.65% | -1324.70% |
| Sep 29, 2026 | $- | $6.88 | +1438.03% | - | |
| Sep 28, 2026 | $- | $6.80 | +1421.25% | - | |
| Sep 25, 2026 | $7.79 | -57.61% | $6.89 | +1441.39% | -1499.00% |
| Sep 24, 2026 | $7.87 | -57.17% | $6.83 | +1427.96% | -1485.13% |
| Sep 23, 2026 | $7.87 | -57.17% | $7.10 | +1488.37% | -1545.54% |
| Sep 22, 2026 | $8.35 | -54.56% | $- | - | |
| Sep 21, 2026 | $8.20 | -55.37% | $7.18 | +1506.26% | -1561.63% |
| Sep 18, 2026 | $7.66 | -58.31% | $7.16 | +1501.79% | -1560.10% |
| Sep 17, 2026 | $7.88 | -57.12% | $7.49 | +1575.62% | -1632.74% |
| Sep 16, 2026 | $7.68 | -58.20% | $7.81 | +1647.20% | -1705.40% |
| Sep 15, 2026 | $8.28 | -54.94% | $9.00 | +1913.42% | -1968.36% |
| Sep 14, 2026 | $9.23 | -49.77% | $11.63 | +2501.79% | -2551.56% |
Page 1 of 5